%0 Journal Article %T Dental pulp stem cells ameliorate D-galactose-induced cardiac ageing in rats. %A El-Akabawy G %A El-Kersh SOF %A El-Kersh AOFO %A Amin SN %A Rashed LA %A Abdel Latif N %A Elshamey A %A Abdallah MAAEM %A Saleh IG %A Hein ZM %A El-Serafi I %A Eid N %J PeerJ %V 12 %N 0 %D 2024 %M 38799055 %F 3.061 %R 10.7717/peerj.17299 %X UNASSIGNED: Ageing is a key risk factor for cardiovascular disease and is linked to several alterations in cardiac structure and function, including left ventricular hypertrophy and increased cardiomyocyte volume, as well as a decline in the number of cardiomyocytes and ventricular dysfunction, emphasizing the pathological impacts of cardiomyocyte ageing. Dental pulp stem cells (DPSCs) are promising as a cellular therapeutic source due to their minimally invasive surgical approach and remarkable proliferative ability.
UNASSIGNED: This study is the first to investigate the outcomes of the systemic transplantation of DPSCs in a D-galactose (D-gal)-induced rat model of cardiac ageing. Methods. Thirty 9-week-old Sprague-Dawley male rats were randomly assigned into three groups: control, ageing (D-gal), and transplanted groups (D-gal + DPSCs). D-gal (300 mg/kg/day) was administered intraperitoneally daily for 8 weeks. The rats in the transplantation group were intravenously injected with DPSCs at a dose of 1 × 106 once every 2 weeks.
UNASSIGNED: The transplanted cells migrated to the heart, differentiated into cardiomyocytes, improved cardiac function, upregulated Sirt1 expression, exerted antioxidative effects, modulated connexin-43 expression, attenuated cardiac histopathological alterations, and had anti-senescent and anti-apoptotic effects.
UNASSIGNED: Our results reveal the beneficial effects of DPSC transplantation in a cardiac ageing rat model, suggesting their potential as a viable cell therapy for ageing hearts.